Jill Henrich, the EVP of $ATRA ($ATRA), sold 1,000 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.9% of their shares. Following...
Atara Biotherapeutics: Q3 Earnings Snapshot
Atara Biotherapeutics: Q2 Earnings Snapshot
This tiny stock could soar more than 400%, according to Wall Street.
Atara Biotherapeutics: Q1 Earnings Snapshot
Atara Biotherapeutics: Q4 Earnings Snapshot
Atara Biotherapeutics: Q3 Earnings Snapshot
Atara Biotherapeutics: Q2 Earnings Snapshot
Atara Biotherapeutics: Q1 Earnings Snapshot
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients...